Profil
Ross Bundy is the founder of CRISPRQC, Inc. He is currently working as the Chief Entrepreneur at Cardea Bio, Inc.
Aktive Positionen von Ross Helgren Bundy
| Unternehmen | Position | Beginn |
|---|---|---|
Cardea Bio, Inc.
 Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
CRISPRQC, Inc.
 CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Health Technology |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Health Technology |
